Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05411744 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Jun 30, 2025 to Jan 16, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Jun 30, 2024 to Jun 30, 2025
    • Study completion date: Jun 30, 2027 to Jun 30, 2029
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Jun 30, 2023 to Jun 30, 2024
    • Study completion date: Jun 30, 2025 to Jun 30, 2027
    • Interventions: Rifapentine (Drug) to 1 month Rifapentine, Isoniazid and Vitamin B6 (Drug)
    • Site details revised
    • Study description shortened, about 2 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, single-center, single-arm, open-label study investigating the safety, compliance and pharmacokinetics of 1-month treatment of Isoniazid, Rifapentine and Vitamin B6 in renal transplant candidates.
Trial Details
NCT Number NCT05411744
Lead Sponsor Rutgers, The State University of New Jersey
Conditions
(from sponsor)		 Latent Tuberculosis, End Stage Renal Disease, Renal Transplant Candidate for Right Kidney, Renal Transplant Candidate for Left Kidney
Related terms Kidney Failure, Chronic, Latent Tuberculosis
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov